Esperion Therapeutics, Inc.
ESPR
Health Care
2
exclusion reasons
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Esperion Therapeutics, Inc. is a pharmaceutical company whose drug development pipeline relies on animal testing. The company’s primary investigational and approved products, which are small-molecule therapies for cardiovascular disease, required preclinical testing on animals to assess efficacy and safety for regulatory submission. This testing is a standard, integral part of the company’s research and development process.
While the specific scale and nature of Esperion's animal testing operations are not detailed in public regulatory filings, the company’s operations fall under the broader pharmaceutical industry practice where animal models are used in drug discovery and toxicity studies. The available evidence from Cruelty Free Investors flags the company within this category, indicating its business model is contingent on the commercial exploitation of animals for biomedical research.
Esperion Therapeutics is a clinical-stage biopharmaceutical company focused on developing oral therapies for patients with elevated low-density lipoprotein cholesterol. The company’s drug development pipeline, including its lead product candidates, requires animal testing to satisfy regulatory requirements for safety and efficacy prior to human clinical trials. This testing is a fundamental and non-optional component of its business model. As a pharmaceutical company, Esperion commissions, funds, and relies on data from animal studies conducted either internally or by contract research organizations as part of the preclinical research and development process.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.